Literature DB >> 4924343

Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.

M D Muenter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4924343

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.

Authors:  C Fehling
Journal:  Z Neurol       Date:  1972

Review 3.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

4.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

5.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

6.  Sinemet-ferrous sulphate interaction in patients with Parkinson's disease.

Authors:  N R Campbell; D Rankine; A E Goodridge; B B Hasinoff; M Kara
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 7.  Drug-induced mania in the elderly.

Authors:  L Ganzini; S B Millar; J R Walsh
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 8.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.